Cerevel Therapeutics Holdings, Inc.

DB:673 Stock Report

Market Cap: €6.9b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Cerevel Therapeutics Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 673?
Owner TypeNumber of SharesOwnership Percentage
Private Companies5,4810.003%
Individual Insiders520,4030.285%
Public Companies27,349,21115%
VC/PE Firms76,474,65741.8%
Institutions78,442,01442.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.9%.


Top Shareholders

Top 25 shareholders own 88.9% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
36.2%
Bain Capital, LP
65,679,781€2.5b9.1%31.84%
15.1%
Pfizer Inc.
27,349,211€1.0b0%no data
5.95%
Perceptive Advisors LLC
10,794,876€408.9m-1.55%8.75%
5.34%
FMR LLC
9,691,851€367.1m0%0.03%
4.16%
Avoro Capital Advisors LLC
7,555,555€286.2m691%3.89%
4.06%
The Vanguard Group, Inc.
7,374,970€279.4m15.8%0.01%
3.32%
BlackRock, Inc.
6,027,525€228.3m20.8%no data
1.57%
State Street Global Advisors, Inc.
2,851,819€108.0m-1.67%no data
1.52%
Fidelity International Ltd
2,766,000€104.8m0%0.05%
1.47%
Rock Springs Capital Management LP
2,674,245€101.3m5.74%2.69%
1.28%
Paradigm Biocapital Advisors LP
2,330,508€88.3m-7.99%4.0%
1.07%
Balyasny Asset Management L.P.
1,941,215€73.5m6,420%0.22%
0.99%
Geode Capital Management, LLC
1,789,302€67.8m24.3%0.01%
0.91%
Alpine Associates Management Inc.
1,644,100€62.3m0%4.14%
0.88%
Baker Bros. Advisors LP
1,600,000€60.6m0%0.71%
0.62%
AllianceBernstein L.P.
1,132,640€42.9m1,150%0.01%
0.61%
Millennium Management LLC
1,111,112€42.1m-47.8%0.04%
0.61%
Pentwater Capital Management LP
1,100,000€41.7m0%0.92%
0.56%
Magnetar Capital Partners, LP
1,018,428€38.6m0%1.47%
0.53%
AQR Capital Management, LLC
953,342€36.1m13,500%0.07%
0.5%
Voloridge Investment Management, LLC
900,024€34.1m0%0.14%
0.48%
Capital Research and Management Company
863,786€32.7m0%no data
0.43%
Westfield Capital Management Company, L.P.
785,494€29.8m-19.4%0.17%
0.41%
Affinity Asset Advisors, LLC
750,000€28.4m9.48%5.89%
0.4%
Westchester Capital Management, LLC
729,310€27.6m0%1.38%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/03/02 04:24
End of Day Share Price 2023/12/04 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cerevel Therapeutics Holdings, Inc. is covered by 16 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Caroline PalomequeBerenberg
Esther Lannie HongBerenberg
Tazeen AhmadBofA Global Research